Cervarix: first human vaccine manufactured with baculovirus expression system
Filed under:
Seminar
Isabelle Knott Director, Head of Cell Culture Development GlaxoSmithKline Biologicals S.A.
| When |
12 Jul, 2011
from
12:00 pm to 01:00 pm |
|---|---|
| Where | Auditorium |
| Add event to your calendar |
iCal
|
ITQB – IBET SEMINAR
Title: “Cervarix: first human vaccine manufactured with baculovirus expression system”
Speaker: Isabelle Knott
Affiliation: Director, Head of Cell Culture Development
GlaxoSmithKline Biologicals S.A., Rixensart, Belgium
Host: Manuel Carrondo
Abstract:
Cervarix, GSK vaccine against cervical cancer, is based on baculovirus expression system. The presentation will address key points about the baculovirus system, the manufacturing of the vaccine including quality and safety assessment of the process.
